Lei, L., Canning, M. T., Marra, A., Switchenko, J., Valenza, C., Madabhushi, A., Badve, S. S., Takabe, K., Sacks, R. L., Kalinsky, K., Gandhi, S. (2026). Overall survival (OS) in premenopausal ER+/PR+, HER2− breast cancer (BC) treated with endocrine therapy (ET) ± chemotherapy (CT): A National Cancer Database (NCDB) analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.519